Fig. 3From: Randomized crossover trial of a modified ketogenic diet in Alzheimer’s diseaseMean within-individual changes in a cognition (ACE-III), b daily function (ADCS-ADL), and c quality of life (QOL-AD) scores (both the actual scores as well as changes in baseline scores are shown) for all randomized patients (n = 26 for ketogenic diet, n = 26 for usual diet). Regarding withdrawals, all data up to the point of withdrawal are shown, with regression imputation used to calculate values for the week(s) post-withdrawal. Error bars indicate standard errorBack to article page